Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Forecasted to Post FY2022 Earnings of ($2.68) Per ...

Retrieved on: 2021-05-07 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Forecasted to Post FY2022 Earnings of ($2.68) Per .... View article details on hiswai:

Excerpt

Neo Ivy Capital Management now owns 3,495 shares of the biopharmaceutical company's stock valued at $111,000 after acquiring an additional 2,623 ...

Article found on: www.marketbeat.com